The Sonalleve MR-HIFU (MR-guided High Intensity Focused Ultrasound) fibroid therapy system, by Philips, offers a non-invasive treatment for uterine fibroids. It combines the power of two modalities by integrating an advanced high intensity focused ultrasound system into the patient table of the Achieva MR system. It uses focused ultrasound waves to heat and coagulate tissue deep inside the body without damaging intervening tissue, and combines this with advanced planning, guidance and temperature monitoring provided by MR. The procedure can be performed on an outpatient basis, with an almost full recovery within a few days.
If you enjoy this content, please share it with a colleague
Related Content
April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...
April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...
April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...
March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...
March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...
March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...
Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...
Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...
Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been ...
Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...